These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35851055)

  • 1. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
    Kared H; Wolf AS; Alirezaylavasani A; Ravussin A; Solum G; Tran TT; Lund-Johansen F; Vaage JT; Nissen-Meyer LS; Nygaard UC; Hungnes O; Robertson AH; Næss LM; Trogstad L; Magnus P; Munthe LA; Mjaaland S
    Nat Commun; 2022 Jul; 13(1):4165. PubMed ID: 35851055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron infection increases IgG binding to spike protein of predecessor variants.
    Mahalingam G; Periyasami Y; Arjunan P; Subaschandrabose RK; Mathivanan TV; Mathew RS; Devi RKT; Premkumar PS; Muliyil J; Srivastava A; Moorthy M; Marepally S
    J Med Virol; 2023 Feb; 95(2):e28419. PubMed ID: 36546401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.
    Woldemeskel BA; Garliss CC; Aytenfisu TY; Johnston TS; Beck EJ; Dykema AG; Frumento N; Wright DA; Yang AH; Damanakis AI; Laeyendecker O; Cox AL; Mostafa HH; Karaba AH; Blankson JN
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35389888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B
    J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
    Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ
    Immunity; 2022 Jul; 55(7):1316-1326.e4. PubMed ID: 35690062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
    Saade C; Brengel-Pesce K; Gaymard A; Trabaud MA; Destras G; Oriol G; Cheynet V; Debombourg M; Mokdad B; Billaud G; Oblette A; Créhalet H; Giannoli JM; Garrigou C; Generenaz L; Compagnon C; Boibieux A; Lina B; Morfin F; Pozzetto B; Josset L; Trouillet-Assant S; Bal A
    Emerg Microbes Infect; 2022 Dec; 11(1):2423-2432. PubMed ID: 36098494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort.
    Hollstein MM; Dierks S; Schön MP; Bergmann A; Abratis A; Eidizadeh A; Kaltenbach S; Schanz J; Groß U; Leha A; Kröger A; Andag R; Zautner AE; Fischer A; Erpenbeck L; Schnelle M
    J Med Virol; 2023 Oct; 95(10):e29122. PubMed ID: 37787583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
    Richardson JR; Götz R; Mayr V; Lohse MJ; Holthoff HP; Ungerer M
    PLoS One; 2022; 17(4):e0266701. PubMed ID: 35468147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin.
    Pušnik J; Zorn J; Monzon-Posadas WO; Peters K; Osypchuk E; Blaschke S; Streeck H
    Nat Commun; 2024 Apr; 15(1):3102. PubMed ID: 38600072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.
    Kaku CI; Bergeron AJ; Ahlm C; Normark J; Sakharkar M; Forsell MNE; Walker LM
    Sci Immunol; 2022 Jul; 7(73):eabq3511. PubMed ID: 35549299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections.
    Stærke NB; Reekie J; Nielsen H; Benfield T; Wiese L; Knudsen LS; Iversen MB; Iversen K; Fogh K; Bodilsen J; Juhl MR; Lindvig SO; Øvrehus A; Madsen LW; Klastrup V; Andersen SD; Juhl AK; Andreasen SR; Ostrowski SR; Erikstrup C; Fischer TK; Tolstrup M; Østergaard L; Johansen IS; Lundgren J; Søgaard OS
    Nat Commun; 2022 Aug; 13(1):4466. PubMed ID: 35915081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
    Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent HE; Tan HX; Rowntree LC; Nguyen THO; Thomas PG; Kedzierska K; Petersen J; Rossjohn J; Williamson DA; Khoury D; Davenport MP; Kent SJ; Wheatley AK; Juno JA
    Immunity; 2023 Apr; 56(4):879-892.e4. PubMed ID: 36958334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.
    Hornsby H; Nicols AR; Longet S; Liu C; Tomic A; Angyal A; Kronsteiner B; Tyerman JK; Tipton T; Zhang P; Gallis M; Supasa P; Selvaraj M; Abraham P; Neale I; Ali M; Barratt NA; Nell JM; Gustafsson L; Strickland S; Grouneva I; Rostron T; Moore SC; Hering LM; Dobson SL; Bibi S; Mongkolsapaya J; Lambe T; Wootton D; Hall V; Hopkins S; Dong T; Barnes E; Screaton G; ; Richter A; Turtle L; Rowland-Jones SL; Carroll M; Duncan CJA; Klenerman P; Dunachie SJ; Payne RP; de Silva TI
    Nat Commun; 2023 Aug; 14(1):5065. PubMed ID: 37604803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
    Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
    Carreño JM; Alshammary H; Tcheou J; Singh G; Raskin AJ; Kawabata H; Sominsky LA; Clark JJ; Adelsberg DC; Bielak DA; Gonzalez-Reiche AS; Dambrauskas N; Vigdorovich V; ; Srivastava K; Sather DN; Sordillo EM; Bajic G; van Bakel H; Simon V; Krammer F
    Nature; 2022 Feb; 602(7898):682-688. PubMed ID: 35016197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.